Dian Daher, DO
Family Medicine · Jacksonville, FLNPI 1417390709
Payments from drug & device makers
Across 317 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$773
- Lilly USA, LLC$645
- Bayer$519
- GSK$463
- AstraZeneca$428
- Novo Nordisk$337
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,465100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $773 |
| Lilly USA, LLC | 37 | $645 |
| Bayer | 31 | $519 |
| GSK | 28 | $463 |
| AstraZeneca | 26 | $428 |
| Novo Nordisk | 22 | $337 |
| Boehringer Ingelheim | 13 | $279 |
| Pfizer | 13 | $274 |
| Sanofi-aventis U.S. LLC | 11 | $228 |
| Abbott | 10 | $208 |
| Evoke Pharma, Inc. | 12 | $206 |
| Daiichi Sankyo Inc. | 6 | $119 |
| Amgen(2 entities) | 5 | $106 |
| Novartis | 6 | $91 |
| Idorsia Pharmaceuticals US Inc | 6 | $88 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Exact Sciences | 3 | $55 |
| Almatica Pharma LLC | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $52 |
| Astellas Pharma US Inc | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 3 | $39 |
| Lundbeck LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $32 |
| Johnson & Johnson | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $21 |
| Bausch Health US, LLC | 1 | $19 |
| Insulet Corporation | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Gilead | 1 | $15 |
How this compares
$5,465 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 98 | $100,931 |
| OzempicSemaglutide | 57 | $55,529 |
| MounjaroTirzepatide | 43 | $45,446 |
| EliquisApixaban | 29 | $30,060 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $22,119 |
| TrulicityDulaglutide | 14 | $15,699 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $7,564 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,691 |
| Wixela InhubFluticasone Propion/Salmeterol | 35 | $3,589 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $2,383 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 69 | $1,819 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $1,778 |
| Celecoxib | 36 | $1,598 |
| Varenicline Tartrate | 13 | $1,429 |
| SynthroidLevothyroxine Sodium | 13 | $1,394 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $279 | $100,93198 claims |
| Lilly USA, LLCMounjaro, Trulicity | $645 | $61,14557 claims |
| Novo NordiskOzempic | $337 | $55,52957 claims |
| PfizerEliquis | $274 | $30,06029 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $463 | $29,68241 claims |
| AstraZenecaSymbicort | $428 | $3,69113 claims |
| AbbVieSynthroid | $773 | $1,39413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Jacksonville
- Jeffry JacqmeinJacksonville$8.7M
- Herman DowneyJacksonville$4.1M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.